Case Report

The novel ZBTB24 mutation identified in an Iranian patient with type 2 ICF syndrome


Autosomal-recessive immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome is mainly determined by recurrent tract respiratory and gastrointestinal infections in early childhood due to agammaglobulinemia. Most patients with ICF syndrome die of infection at a young age, usually in the first or second decade of life. The leading cause of ICF disorders is mutations in genes whose products play a role in DNA methylation. ICF syndrome is classified into two groups: type 1 (ICF1) patients have mutations in the DNMT3B gene, and about half of type 2 (ICF2) patients have mutations in the ZBTB24 gene. In this study, we report the case of a 34-year-old female of Iranian consanguineous parents, who was diagnosed at one year of age with ICF-2 syndrome with recurrent infections, mental retardation, and a homozygous novel mutation in the ZBTB24 gene.

IssueVol 4, No 3 (2021) QRcode
SectionCase Report
Chromosomal instability Immunodeficiency-centromeric instability-facial anomalies syndrome mental retardation

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Arshi S, Nabavi M, Bemanian MH, Fallahpour M, Delavari S, Rezaei N, Shokri S. The novel ZBTB24 mutation identified in an Iranian patient with type 2 ICF syndrome. Immunol Genet J. 2021;4(3):166-170.